The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: infliximab     Quarter: 2016Q3

Total Records: 643     Number of Pages: 33

DRUGNAME PT EventCount
INFLIXIMAB, RECOMBINANT Fusarium infection 1
INFLIXIMAB, RECOMBINANT Gastrointestinal motility disorder 1
INFLIXIMAB, RECOMBINANT Groin abscess 1
INFLIXIMAB, RECOMBINANT Haemorrhage 1
INFLIXIMAB, RECOMBINANT Headache 1
INFLIXIMAB, RECOMBINANT Hepatic enzyme increased 1
INFLIXIMAB, RECOMBINANT Hepatitis B 1
INFLIXIMAB, RECOMBINANT Herpes simplex 1
INFLIXIMAB, RECOMBINANT Herpes virus infection 1
INFLIXIMAB, RECOMBINANT Horner's syndrome 1
INFLIXIMAB, RECOMBINANT Hyperhidrosis 1
INFLIXIMAB, RECOMBINANT Hypertensive crisis 1
INFLIXIMAB, RECOMBINANT Hypotension 1
INFLIXIMAB, RECOMBINANT Ileal stenosis 1
INFLIXIMAB, RECOMBINANT Immune reconstitution inflammatory syndrome associated tuberculosis 1
INFLIXIMAB, RECOMBINANT Immunosuppression 1
INFLIXIMAB, RECOMBINANT Inflammatory bowel disease 1
INFLIXIMAB, RECOMBINANT Injection site reaction 1
INFLIXIMAB, RECOMBINANT Interstitial lung disease 1
INFLIXIMAB, RECOMBINANT Intestinal ischaemia 1

Total Records: 643     Number of Pages: 33